Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
BMJ Case Rep
; 15(11)2022 Nov 22.
Статья
в английский
| MEDLINE | ID: covidwho-2137567
ABSTRACT
A previously healthy Japanese woman in her 20s was admitted to our hospital with a 2-week history of fever (39.0°C) and a 1-week history of painful cervical lymphadenopathy. The day before fever onset, she had received her first Pfizer-BioNTech SARS-CoV-2 vaccine in her left arm. She had previously been treated with empirical antibiotics with no improvement. Physical examination revealed painful lymphadenopathy in both posterior cervical regions. CT showed symmetrical lymphadenopathies in the neck, supraclavicular, axillary and inguinal regions as well as hepatosplenomegaly. We suspected lymphoma and performed a lymph node biopsy in the right inguinal region, which revealed necrotising histiocytic lymphadenitis. The patient was, therefore, diagnosed with Kikuchi-Fujimoto disease (KFD). She improved after the corticosteroid therapy. This report highlights the importance of including KFD as a differential diagnosis of lymphadenopathy after SARS-CoV-2 vaccination. Additionally, lymph node biopsy is helpful for diagnosing KFD because it rules out other entities.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Histiocytic Necrotizing Lymphadenitis
/
Lymphadenopathy
/
COVID-19
Тип исследования:
История болезни
/
Диагностическое исследование
/
Прогностическое исследование
Темы:
Длинный Ковид
/
Вакцина
Пределы темы:
Женщины
/
Люди
Язык:
английский
Год:
2022
Тип:
Статья
Аффилированная страна:
Bcr-2022-250601
Документы, близкие по теме
MEDLINE
...
LILACS
LIS